LRRK2 and Parkinson disease: LRRK2 was previously shown to negatively regulate protein kinase A activity in LRRK2-enriched striatal projection neurons (SPN), supporting a pathogenic mechanism of SPN dysfunction in Parkinson’s disease (PD) [60].